This table summarizes the various blood, urine, and tissue PCMs (prostate cancer biomarkers) discussed on this website. Utilizing this table, in conjunction with the advise of your physician, can help aid in determining which PCM is right for you.
This is a copy of our printable algorithm for how to screen men for prostate cancer. Our algorithm is based on a PSA cutoff of 1.5 (see our paper in the references and download section). To learn more about each individual biomarker, please click here.
Learn about prostate cancer diagnosis, staging, what a Gleason Score means, and prostate cancer risk groups.
This link, provided by the American Cancer Society (ACS), has important information about a prostate biopsy, how prostate cancer is staged, what a Gleason Score means, and the different risk groups of men who are diagnosed with prostate cancer.
Despite the US Preventive Services Task Force 2012 recommendation against PSA screening, we published a paper we believe should be incorporated into screening men for early detection of prostate cancer.